Published • loading... • Updated
Health Canada warns doctors not to start this prescription medication
Health Canada is reviewing TAVNEOS after questions about trial data integrity and is advising doctors to monitor current patients, with the drug approved for severe ANCA vasculitis.
Summary
3 Articles
3 Articles
Is your prescription for this medication safe? Health Canada reviews one drug's efficacy amid rising concerns of patients' health
Health Canada said Tavneos was authorized in Canada following review of information available at the time, including a key clinical trial. The agency said new information “has raised serious concerns” about the reliability of that data.
·Hamilton, Canada
Read Full Article
Health Canada warns doctors not to start this prescription medication
Health Canada is reviewing the evidence supporting TAVNEOS after concerns emerged about the integrity of data from its key clinical trial. In the meantime, doctors are being told not to start new patients on the drug while the review continues.
·Canada
Read Full ArticleCoverage Details
Total News Sources3
Leaning Left1Leaning Right0Center2Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
L 33%
C 67%
Factuality
To view factuality data please Upgrade to Premium
